Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 11718

1.

P2Y12 antagonists in non-ST-segment elevation acute coronary syndromes: latest evidence and optimal use.

Norgard NB, DiNicolantonio JJ.

Ther Adv Chronic Dis. 2015 Jul;6(4):204-218. Review.

PMID:
26137210
2.

Usefulness of delta troponin for diagnosis and prognosis assessment of non-ST-segment elevation acute chest pain.

Sanchis J, Abellán L, García-Blas S, Mainar L, Mollar A, Valero E, Consuegra-Sánchez L, Roqué M, Bertomeu-González V, Chorro FJ, Núñez E, Núñez J.

Eur Heart J Acute Cardiovasc Care. 2015 Jul 1. pii: 2048872615593534. [Epub ahead of print]

PMID:
26136512
3.

Comparison of documentation and evidence-based medicine use for non-ST-segment elevation myocardial infarction among cardiology, teaching, and nonteaching teams.

Metting A, Binz D, Colbert CY, Song J, Chiles C, Mirkes C.

Proc (Bayl Univ Med Cent). 2015 Jul;28(3):312-6.

PMID:
26130875
4.

Targeting reperfusion injury in the era of primary percutaneous coronary intervention: hope or hype?

Lønborg JT.

Heart. 2015 Jun 30. pii: heartjnl-2015-307804. doi: 10.1136/heartjnl-2015-307804. [Epub ahead of print] Review.

PMID:
26130664
5.

Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial.

Madhavan MV, Généreux P, Kirtane AJ, Xu K, Witzenbichler B, Mehran R, Stone GW.

Eur Heart J Acute Cardiovasc Care. 2015 Jun 29. pii: 2048872615592246. [Epub ahead of print]

PMID:
26124455
6.

Time from symptom onset influences high-sensitivity troponin T diagnostic accuracy for the diagnosis of acute myocardial infarction.

Guangquan L, Hualan H, Xin N, Yong H, Haolan S, Tongxing L, Baoxiu G, Hu N, Guixing L.

Clin Chem Lab Med. 2015 Jun 27. pii: /j/cclm.ahead-of-print/cclm-2014-0776/cclm-2014-0776.xml. doi: 10.1515/cclm-2014-0776. [Epub ahead of print]

PMID:
26124053
7.

Angiographic Lesion Complexity Score and In-Hospital Outcomes after Percutaneous Coronary Intervention.

Endo A, Kawamura A, Miyata H, Noma S, Suzuki M, Koyama T, Ishikawa S, Nakagawa S, Takagi S, Numasawa Y, Fukuda K, Kohsaka S; JCD-KICS Investigators.

PLoS One. 2015 Jun 29;10(6):e0127217. doi: 10.1371/journal.pone.0127217. eCollection 2015.

8.

Accessibility to Reperfusion Therapy Among Women with Acute Myocardial Infarction: Impact on Hospital Mortality.

de-Miguel-Balsa E, Latour-Pérez J, Baeza-Román A, Llamas-Álvarez A, Ruiz-Ruiz J, Fuset-Cabanes MP.

J Womens Health (Larchmt). 2015 Jun 29. [Epub ahead of print]

PMID:
26121263
9.

Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: The nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial.

Nijhoff F, Agostoni P, Belkacemi A, Nathoe HM, Voskuil M, Samim M, Doevendans PA, Stella PR.

Catheter Cardiovasc Interv. 2015 Jun 29. doi: 10.1002/ccd.26060. [Epub ahead of print]

PMID:
26119971
10.

Early Phase Arterial Reaction Following Drug-Eluting and Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction.

Nishio R, Shinke T, Morino Y, Tanabe K, Furuya J, Takizawa K, Ako J, Kozuma K, Hibi K, Ishii H, Hirohata A, Otsuka Y, Otake H, Takaya T, Hirata KI.

Int Heart J. 2015 Jun 26. [Epub ahead of print]

11.

Prehospital Transfer Pathway and Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention.

Imori Y, Akasaka T, Shishido K, Ochiai T, Tobita K, Yamanaka F, Mizuno S, Saito S.

Circ J. 2015 Jun 26. [Epub ahead of print]

12.

[BIOMARKER CONTENT AND ROLE IN HOSPITAL PERIOD OF ACUTE CORONARY SYNDROME].

Mikhailova ZD, Shalenkova MA, Manyukova ET.

Klin Med (Mosk). 2015;93(2):47-52. Russian.

PMID:
26117918
13.

A Combined Optical Coherence Tomography and Intravascular Ultrasound Study on Plaque Rupture, Plaque Erosion, and Calcified Nodule in Patients With ST-Segment Elevation Myocardial Infarction: Incidence, Morphologic Characteristics, and Outcomes After Percutaneous Coronary Intervention.

Higuma T, Soeda T, Abe N, Yamada M, Yokoyama H, Shibutani S, Vergallo R, Minami Y, Ong DS, Lee H, Okumura K, Jang IK.

JACC Cardiovasc Interv. 2015 Jun 16. pii: S1936-8798(15)00695-0. doi: 10.1016/j.jcin.2015.02.026. [Epub ahead of print]

PMID:
26117464
14.

Outcomes of Comatose Cardiac Arrest Survivors With and Without STEMI: Importance of Coronary Angiography.

Kern KB, Lotun K, Patel N, Mooney MR, Hollenbeck RD, McPherson JA, McMullan PW, Unger B, Hsu CH, Seder DB; INTCAR-Cardiology Registry (International Cardiac Arrest Registry-Cardiology Database).

JACC Cardiovasc Interv. 2015 Jun 16. pii: S1936-8798(15)00679-2. doi: 10.1016/j.jcin.2015.02.021. [Epub ahead of print]

PMID:
26117462
15.

Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.

Oksuz F, Yarlioglues M, Cay S, Celik IE, Mendi MA, Kurtul A, Cankurt T, Kuyumcu S, Canpolat U, Turak O.

Am J Cardiol. 2015 Jun 4. pii: S0002-9149(15)01426-5. doi: 10.1016/j.amjcard.2015.05.042. [Epub ahead of print]

PMID:
26116992
16.

Electrocardiographic evolution in patients with hypertrophic cardiomyopathy who develop a left ventricular apical aneurysm.

Pennacchini E, Musumeci MB, Conte MR, Stöllberger C, Formisano F, Bongioanni S, Francia P, Volpe M, Autore C.

J Electrocardiol. 2015 Jun 4. pii: S0022-0736(15)00185-5. doi: 10.1016/j.jelectrocard.2015.06.004. [Epub ahead of print]

PMID:
26116312
17.

Platelet effect of prasugrel and ticagrelor in patients with ST-segment elevation myocardial infarction.

Kerneis M, Silvain J, Abtan J, Hauguel M, Barthélémy O, Payot L, Brugier D, Galier S, Collet JP, Montalescot G.

Arch Cardiovasc Dis. 2015 Jun 22. pii: S1875-2136(15)00106-0. doi: 10.1016/j.acvd.2015.04.004. [Epub ahead of print]

PMID:
26113480
18.

Utilization of modified diagnostic ultrasound and microbubbles to reduce myocardial infarct size.

Wu J, Xie F, Lof J, Sayyed S, Porter TR.

Heart. 2015 Jun 24. pii: heartjnl-2015-307625. doi: 10.1136/heartjnl-2015-307625. [Epub ahead of print]

PMID:
26109588
19.

Factors Associated with the Use of Drug-Eluting Stents in Patients Presenting with Acute ST-Segment Elevation Myocardial Infarction.

Chavez JF, Doll JA, Mediratta A, Maffessanti F, Friant J, Paul JD, Blair JE, Nathan S, Jolly N, Shah AP.

Cardiol Res Pract. 2015;2015:528753. doi: 10.1155/2015/528753. Epub 2015 May 28.

20.

High-grade culprit lesions are a common cause of ST-segment elevation myocardial infarction.

Liang M, Kajiya T, Chan MY, Tay E, Lee CH, Richards AM, Low AF, Tan HC.

Singapore Med J. 2015 Jun;56(6):334-8. doi: 10.11622/smedj.2015092.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk